After £21m UK deal, NZ’s Kode Biotech says IPO is option

Third licensing deal in the works.   Chris Keall talks about Kode Biotech on NBR Radio and on demand via MyNBR Radio.
 

Want to read more?

Choose a Subscription type that's right for you HERE
Already have an account? Login